Innovative Biomarker and Precision Medicine
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".
Deadline for manuscript submissions: closed (26 August 2022) | Viewed by 22775
Special Issue Editors
2. Inflammation Society, Bexley DA52EL, UK
Interests: applied nutrition; chronic inflammation; glycation; advanced glycation end products; nutrition immunology; personalized nutrition; hepatitis; NASH; NAFLD; liver diseases
Special Issues, Collections and Topics in MDPI journals
Interests: biostatistics; nutrition; inflammation; nutrition immunology; medical research
Special Issues, Collections and Topics in MDPI journals
Interests: diabetes; prediabetes; type 2 diabetes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Medicine is rapidly evolving towards a precise and tailored approach to diseases. From cancer care in an ultra-specialistic setting to general practice, quality medicine no longer uses a “one fits all” approach, but the discovery of novel biomarkers and treatments enables physicians to personalize their approach on an individual basis. From gene therapy to diabetes care, the increasing number of drugs and mechanisms involved underlines that many different aspects vary in the same disease, and a better understanding and early identification of these differences could provide a great contribution to delivering a more effective treatment, without delays and side effects, which could increase patient compliance, still found to be a main obstacle in the treatment of chronic conditions.
This Special Issue focuses on the identification of possible innovative biomarkers able to advance the understanding of the pathophysiology behind diseases, recognizing them at earlier stages and identifying different phenotypes; thus, guiding different treatments.
Dr. Mattia Cappelletti
Prof. Dr. Giuseppe Derosa
Dr. Michela Carola Speciani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- precision medicine
- novel biomarkers
- disease treatment
- pathophysiology
- disease phenotypes